Tissue Regenix Group plc (AIM:TRX)
London
· Delayed Price · Currency is GBP · Price in GBX 32.85
+0.35 (1.08%)
May 9, 2025, 12:32 PM GMT+1
Tissue Regenix Group Market Cap
Tissue Regenix Group has a market cap or net worth of 23.15 million as of May 9, 2025. Its market cap has decreased by -46.54% in one year.
Market Cap
23.15M
Enterprise Value
28.15M
Revenue
25.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.85
Market Cap Chart
Since June 29, 2010, Tissue Regenix Group's market cap has decreased from 41.00M to 23.15M, a decrease of -43.54%. That is a compound annual growth rate of -3.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 165.92B |
| GSK plc | 58.67B |
| Haleon | 36.11B |
| Smith & Nephew | 9.34B |
| ConvaTec Group | 5.36B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.37B |